Clinical trials
Hypertension trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
214 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 10 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 14 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 13 |
| 2015 | 6 |
| 2016 | 9 |
| 2017 | 13 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 8 |
| 2021 | 11 |
| 2022 | 12 |
| 2023 | 13 |
| 2024 | 7 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 127 |
| Unknown status | 26 |
| Terminated | 24 |
| Recruiting | 22 |
| Active, not recruiting | 7 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 11 |
| Queen Mary University of London | 9 |
| Cambridge University Hospitals NHS Foundation Trust | 7 |
| Imperial College London | 7 |
| St George's, University of London | 7 |
| University of Edinburgh | 7 |
| Medtronic Vascular | 6 |
| University of Oxford | 6 |
| Alnylam Pharmaceuticals | 5 |
| Boehringer Ingelheim | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 214 |
| Cardiovascular Diseases | 32 |
| Vascular Diseases | 18 |
| Diabetes Mellitus | 16 |
| Renal Insufficiency, Chronic | 15 |
| Diabetes Mellitus, Type 2 | 10 |
| Obesity | 9 |
| Essential Hypertension | 8 |
| Stroke | 8 |
| Heart Failure | 7 |
Trials
Showing 51 to 75 of 214. Each trial links to its page on Pharma Observatory.
114 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.